Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News United Therapeutics Corp UTHR

Healthcare Biotechnology
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended... see more

Recent & Breaking News (NDAQ:UTHR)

United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

PR Newswire April 1, 2021

United Therapeutics Corporation To Present At The 10th Annual J.P. Morgan Napa Valley Forum

PR Newswire March 24, 2021

United Therapeutics Corporation To Present At The Oppenheimer 31st Annual Healthcare Conference

PR Newswire March 9, 2021

United Therapeutics Corporation To Present At The 41st Annual Cowen Health Care Conference

PR Newswire February 24, 2021

United Therapeutics Corporation Reports Fourth Quarter And Full Year 2020 Financial Results

PR Newswire February 24, 2021

United Therapeutics Corporation To Report Fourth Quarter And Full Year 2020 Financial Results Before The Market Opens On Wednesday, February 24, 2021

PR Newswire February 17, 2021

United Therapeutics Announces Commercial Launch Of The Remunity® Pump For Remodulin®

PR Newswire February 10, 2021

United Therapeutics Announces BREEZE Study of Investigational Tyvaso DPI(TM) Meets Primary Objective

PR Newswire January 28, 2021

3D Systems Announces Breakthrough in Bioprinting Technology and Expansion of Regenerative Medicine Initiative

GlobeNewswire January 27, 2021

United Therapeutics Announces New England Journal of Medicine Publication of the INCREASE Study Evaluating Tyvaso® in Pulmonary Hypertension Associated with Interstitial Lung Disease

PR Newswire January 13, 2021

United Therapeutics Corporation To Present At The 39th Annual J.P. Morgan Healthcare Conference

PR Newswire January 4, 2021

Y-mAbs Announces Sale of Priority Review Voucher

GlobeNewswire December 28, 2020

United Therapeutics Announces Agreement To Acquire Priority Review Voucher

PR Newswire December 28, 2020

United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis

PR Newswire December 9, 2020

United Therapeutics Releases Its First Corporate Responsibility Report

PR Newswire November 24, 2020

United Therapeutics Corporation To Present At The Jefferies Virtual London Healthcare Conference

PR Newswire November 10, 2020

United Therapeutics Corporation To Present At The Credit Suisse 29th Annual Virtual Healthcare Conference

PR Newswire November 2, 2020

United Therapeutics Corporation Reports Third Quarter 2020 Financial Results

PR Newswire October 28, 2020

United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 Meeting

PR Newswire October 22, 2020

United Therapeutics Corporation To Report Third Quarter 2020 Financial Results Before The Market Opens On Wednesday, October 28, 2020

PR Newswire October 21, 2020